PATENT CLAIM ANALYSIS

Application Number: 15993232
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "699000"]

Abstract:
The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative dieses associated with abnormal accumulation of protein tau.

Claim (Index 5):
The method according to  claim 1 , wherein the compound is Compound 23:

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14390960', '15414242', '14486679', '13810362', '13884061']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7314618625900869
- 35 USC 102 Novelty (BERT): 0.5322392656785945
- Combined Prediction Score: 0.7115396028989377
- Mean Citation Score: 268.594884
- Max Citation Score: 342.55923
- Similarity Product: 305.50801720167163

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test